Angiotensin II receptor blocker-based vs. non-angiotensin II receptor blocker-based therapy in patients with angiographically documented coronary artery disease and hypertension: the Heart Institute of Japan Candesartan Randomized Trial for Evaluation in Coronary Artery Disease (HIJ-CREATE)

2010 ◽  
Vol 2010 ◽  
pp. 80-81
Author(s):  
W.J. Elliott
Sign in / Sign up

Export Citation Format

Share Document